Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Required Cross Flow Rate (at 2000/sec) lpm
4.4
Required Cross Flow Rate (at 4000/sec) lpm
8.8
Required Cross Flow Rate (at 8000/sec) lpm
18
Required Cross Flow Rate (at 16000/sec) lpm
35
Operating Temp.
Up to 50°C
Certificate of Analysis
Yes
Feed pressure max. at 25°C
1 bar
0.75 mm,60 cm,5.1 cm (2 in),0.6 µm,Other
¥49,155.00
RTPCFP-1-E-3MS
产品详情
1 mm,30 cm,0.9 cm (0.375 in),0.1 μm,Other
无菌 ReadyToProcess 中空纤维滤器 0.1 μm,纤维内径 1 mm,3 M 号外壳,C-Flex® 管
Application
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Required Cross Flow Rate (at 2000/sec) lpm
0.150 lpm
Required Cross Flow Rate (at 4000/sec) lpm
0.3 lpm
Required Cross Flow Rate (at 8000/sec) lpm
0.6 lpm
Required Cross Flow Rate (at 16000/sec) lpm
1.2 lpm
Operating Temp.
up to 80°C
Certificate of Analysis
Yes
Feed pressure max. at 25°C
2.1 bar
1 mm,30 cm,0.9 cm (0.375 in),0.1 μm,Other
¥12,543.00
RTPCFP-4-E-3MS
产品详情
1 mm,30 cm,0.9 cm (0.375 in),0.45 µm,Other
无菌 ReadyToProcess 中空纤维滤器 0.45 μm,纤维内径 1 mm,3 M 号外壳,C-Flex® 管
生物反应性试验,活体试验,根据 USP 88 VI 级 L929 MEM 洗脱试验 – ISO 10993-5(细胞毒性) 溶血 – 兔血(直接接触)– ISO 10993-4 使用符合 EMEA/410/01 的材料制造
所需的切向流速(2000/秒)lpm
150
所需的切向流速(4000/秒)lpm
300
所需的切向流速(8000/秒)lpm
600
所需的切向流速(16000/秒)lpm
1200
操作温度
最高 50°C
质检报告
是
进料压力最大值 (25°C)
1 bar
1 mm,30 cm,0.9 cm (0.375 in),0.45 µm,Other
¥12,543.00
RTPCFP-1-E-4MS
产品详情
1 mm,30 cm,1.9 cm (0.75 in),0.1 μm,Other
无菌 ReadyToProcess 中空纤维滤器 0.1 μm,纤维内径 1 mm,4 M 号外壳,AdvantaPure 管
Application
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Required Cross Flow Rate (at 2000/sec) lpm
600
Required Cross Flow Rate (at 4000/sec) lpm
1200
Required Cross Flow Rate (at 8000/sec) lpm
2500
Required Cross Flow Rate (at 16000/sec) lpm
5000
Operating Temp.
up to 80°C
Certificate of Analysis
Yes
Feed pressure max. at 25°C
2.1 bar
1 mm,30 cm,1.9 cm (0.75 in),0.1 μm,Other
¥18,306.00
RTPCFP-2-E-4MS
产品详情
1 mm,30 cm,1.9 cm (0.75 in),0.2 µm,Other
无菌 ReadyToProcess 中空纤维滤器 0.2 μm,纤维内径 1 mm,4 M 号外壳,AdvantaPure 管
Application
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Required Cross Flow Rate (at 2000/sec) lpm
600
Required Cross Flow Rate (at 4000/sec) lpm
1200
Required Cross Flow Rate (at 8000/sec) lpm
2500
Required Cross Flow Rate (at 16000/sec) lpm
5000
Operating Temp.
Up to 80°C
Certificate of Analysis
Yes
Feed pressure max. at 25°C
1.7 bar
1 mm,30 cm,1.9 cm (0.75 in),0.2 µm,Other
¥18,306.00
RTPCFP-4-E-4MS
产品详情
1 mm,30 cm,1.9 cm (0.75 in),0.45 µm,Other
无菌 ReadyToProcess 中空纤维滤器 0.45 μm,纤维内径 1 mm,4 M 号外壳,AdvantaPure 管
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01